Source / episode info

• **Episode:**348
• **Title:**Divine Intervention Episode 348 – The Clutch Hypercalcemia Podcast (Step 1-3)
• **Published:**2021-11-06
• Source:Episode page

One-liner

This episode provides a comprehensive review of hypercalcemia, covering classic symptoms (stones, bones, groans, psychic overtones), differentiating parathyroid disorders (PHPT vs FHH), and detailing mechanisms from malignancy (PTHrP, MM), granulomatous disease, and drug-induced states.

High-yield summary

• Symptoms: Classic signs include "Stones" (Nephrolithiasis/nephrocalcinosis), "Bones" (Bone pain), "Groans" (GI symptoms like constipation/abdominal pain), and "Psychic overtones" (Altered mental status, lethargy).
• Initial Management: Symptomatic hypercalcemia requires immediate treatment with Normal Saline IV fluids, followed by IV Calcium Toning or Bisphosphonates.
• PTHrP Source: The most common cause of malignancy-associated hypercalcemia is due to the secretion of Parathyroid Hormone-related Peptide (PTHrP), classically seen in Squamous Cell Lung Cancer.
• Granulomatous Disease: Any granulomatous process (Sarcoidosis, Histoplasmosis, TB, Wegener's/GPA) can cause hypercalcemia via Vitamin D excess, as activated macrophages express 1--hydroxylase, increasing calcitriol synthesis and gut calcium reabsorption.
• FHH vs PHPT: In Familial Hypocalciuric Hypercalcemia (FHH), blood calcium is high but urinary calcium excretion is low due to a defect in the Calcium Sensing Receptor (CaSR). This condition typically requires no treatment.
• Renal Bone Disease Progression: Secondary hyperparathyroidism (CKD) leads to high PTH and high phosphate; if kidneys are replaced, tertiary hyperparathyroidism occurs because parathyroid glands become autonomous, continuing excessive PTH secretion.

Learning objectives

• Differentiate the mechanisms and clinical presentations of primary vs. familial hypercalcemia.
• Recognize the classic signs and symptoms associated with severe hypercalcemia ("Stones, Bones, Groans, Psychic overtones").
• Identify the specific causes of PTHrP secretion (e.g., Squamous Cell Lung Cancer).
• Understand the pathophysiology linking granulomatous disease to elevated calcitriol levels.
• Apply knowledge of renal bone disease progression (Secondary -> Tertiary hyperparathyroidism) and appropriate management strategies.